Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||
| Net Income | -3,986 | -13,070 | -9,915 |
| Depreciation Amortization | 76 | 298 | 220 |
| Accounts payable and accrued liabilities | 221 | N/A | N/A |
| Other Working Capital | 633 | 329 | 222 |
| Other Operating Activity | 44 | 407 | 93 |
| Operating Cash Flow | $-3,012 | $-12,036 | $-9,380 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -368 | -388 | -869 |
| Purchase Of Investment | -13,369 | N/A | N/A |
| Other Investing Activity | 0 | 8,060 | -8,350 |
| Investing Cash Flow | $-13,737 | $7,672 | $-9,219 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 219 | N/A | N/A |
| Other Financing Activity | 119,847 | 16,183 | 22,486 |
| Financing Cash Flow | $120,066 | $16,183 | $22,486 |
| Beginning Cash Position | 20,101 | 7,992 | 4,105 |
| End Cash Position | 123,418 | 19,811 | 7,992 |
| Net Cash Flow | $103,317 | $11,819 | $3,887 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,012 | -12,036 | -9,380 |
| Capital Expenditure | -368 | N/A | N/A |
| Free Cash Flow | -3,380 | -12,036 | -9,380 |